ADIPOQ and diabetes mellitus: Additional evidence of decreased hepatic insulin sensitivity and poor response to agonists of PPARs in adiponectin-deficient mice suggests that adiponectin can slow the progression of diabetes by directly affecting insulin sensitivity [143].